Navigation Links
Chiltern Wins Two Pharma Awards at the Prestigious Annual Pharmatimes Awards Ceremony
Date:2/17/2012

LONDON, Feb. 17, 2012 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Chiltern has won two awards at the PharmaTimes Annual Awards 2011 ceremony held February 16, 2012 at the Park Plaza Riverbank Hotel in London. The competition, established in 1999, celebrates the competence and ability of top clinical research professionals.

Glenn Kerkhof, Chiltern CEO, congratulates all of Chiltern's Award Winners and Finalists. "I couldn't be more proud of every Chiltern colleague nominated for an award and this recognition is a testament to their outstanding abilities. Their achievements support Chiltern's mission to deliver high quality services around the world, while demonstrating our commitment to clients' needs."

Linda Christmas, Sr. Executive VP, Global Resourcing Solutions, Chiltern, stated, "I am delighted that our finalists represent not only Chiltern's outstanding operational people but also our dedicated and professional recruitment team. This further demonstrates not only our ability to deliver world class operational services via our internal teams, but also to place exceptional talent direct with our clients and furthermore an outstanding recruitment and personnel placement service. I am absolutely delighted to be able to work with such a great team each and every day."

Chiltern Award WinnersClinical Recruiter of the Year Bronze Award: Marc Joseph, Resourcing Manager, Chiltern Resourcing Solutions

Clinical Research Associate of the Year Silver Award: Danielle Fairclough, client based Clinical Research Professional via Chiltern Resourcing Solutions

Company profileAbout Chiltern:Established in 1982, Chiltern is a leading global clinical CRO with extensive experience in the management of Phase I-IV clinical trials across a broad range of therapeutic areas, functional service provision and contract staffing solutions. Chiltern has conducted trials in more than 40 countries, employs nearly 1,300 people globally and offers services in Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. Chiltern prides itself as a development partner that offers flexibility, responsiveness and quality delivery. Further information is available at: www.chiltern.com.

 For More Information Contact: 

 Natalie Chong

Susan OjanenMarketing Director

Marketing ExecutiveChiltern International Ltd.

Chiltern International Inc.171 Bath Road

1241 Volunteer Parkway, Suite 950Slough, Berkshire SL1 4AA

Bristol, TN 3762UNITED KINGDOM

USATel:  +44 (0) 1753 512 000

Tel:  +1 (423) 968 9533Email: natalie.chong@chiltern.com

Email: susan.ojanen@chiltern.com 

 


'/>"/>

SOURCE Chiltern
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Chiltern Expands North American Operations With a New Office in Illinois
2. Chiltern - Spectratox Drug Photoxicity Collaboration Celebrates 25 Years
3. Chiltern Wins Multiple Pharma Awards at the Prestigious Annual PharmaTimes Awards Ceremony
4. NABP Supports Legislation Aimed to Protect Patients from Counterfeit Drugs and Fake Online Pharmacies
5. SCOLR Pharma, Inc. Launches Cutting Edge Nutritional Products at Major Retailers in 2012
6. Access Pharmaceuticals MuGard Added to Nationally Ranked Childrens Hospital of Colorado Pharmacy Formulary
7. PDL BioPharma to Announce Fourth Quarter and Full Year 2011 Financial Results on February 23, 2012
8. Questcor Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors
9. IntegriChain Delivers Pharmacy Level Inventory Metrics
10. ViroPharma to Release 2011 Fourth Quarter and Full Year Financial Results on February 28, 2012
11. American Academy of Dermatology and LEO Pharma Launch Educational Website to Raise Awareness About Sun Damage and Skin Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... , May 3, 2016 ... bekannt, dass sie einen entscheidenden Meilenstein durch ... Ein Aufruf zum Handeln, um Patientenresultate  bei ... trägt zu Fortschritten im Verständnis der Hepatischen ... ein Bewusstsein für Hepatische Enzephalopathie in der ...
(Date:5/2/2016)... , May 2, 2016  Celsion Corporation (NASDAQ: ... company, today announced data from the first cohort ... clinical trial (the OVATION Study) combining GEN-1, the ... for the treatment of newly-diagnosed patients with advanced ... by interval debulking surgery.  In the first three ...
(Date:4/29/2016)... , April 29, 2016 ... Directeur Financier Sanofi, leader ... publie ses résultats pour le premier ... Groupe, Jérôme Contamine, commente les résultats ... les perspectives pour le reste de ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... , ... Francesca Loparco, Co-Founder of Queen City Dream Cars, an exotic car ... procedure at Christenbury Eye Center. The entrepreneur struggled with her computer, riding horses ... day as her in-office consultation and eye exam. Francesca’s eyesight was restored to 20/20 ...
(Date:5/4/2016)... ... May 04, 2016 , ... Bayco Products ... tactical (6.7 inch) dual-light flashlights in models NSP-9842XL and NSR-9844XL . , ... starting at $59.95) uses 2 included CR-123 batteries to produce up to 650 ...
(Date:5/4/2016)... ... May 04, 2016 , ... Warren L. Smith M.D. , ... called UTIs, have plagued people since the beginning of recorded medical history, and ... infections every year. It's not just a matter of inconvenience; bladder infections cost us ...
(Date:5/4/2016)... ... 04, 2016 , ... DESCO Medical Service, also known as ... sterilization service and sales company located in Pennsylvania. The terms of the deal ... asset management services to the medical and academic research industries. The acquisition will ...
(Date:5/4/2016)... ... May 04, 2016 , ... Vasont Systems, a ... Integrator (VUI) extension supports the latest release of Adobe FrameMaker, Release 2015. The ... the process of creating, editing and storing XML. , The VUI ...
Breaking Medicine News(10 mins):